Anthranilic acid derivative

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S345000, C514S354000, C546S001000, C546S290000, C546S314000

Reexamination Certificate

active

06890932

ABSTRACT:
The present invention relates to an anthranilic acid derivative expressed by the following formula (1) or the following formula (2), or its pharmacologically permissible salt or solvate. 

REFERENCES:
patent: 0 763523 (1997-03-01), None
patent: 1-287066 (1989-11-01), None
patent: 1-106818 (1990-04-01), None
patent: 5-9170 (1993-01-01), None
patent: 733743 (1995-02-01), None
patent: 7-97350 (1995-04-01), None
patent: 7-285858 (1995-10-01), None
patent: 9012001 (1990-10-01), None
patent: 9525723 (1995-09-01), None
patent: 9532943 (1995-12-01), None
patent: 9719910 (1997-06-01), None
M. Hasegawa, et al., Journal of Medicinal Chemistry, 1997, vol. 40, No. 4, 395-407, “Novel Naphthalene Derivatives as Inhibitors of Human Immunoglobulin E Antibody Production.”

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anthranilic acid derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anthranilic acid derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthranilic acid derivative will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3454384

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.